       Document 0648
 DOCN  M9590648
 TI    Gene transfer trial. Clearinghouse, P.O. Box 6003, Rockville, MD
       20849-6003. 800-458-5231 ext. 5023.
 DT    9509
 SO    Treat Review. 1995 Jan;(no 16):2. Unique Identifier : AIDSLINE
       AIDS/95700309
 AB    A new gene therapy called HIV-IT is in clinical trials for the treatment
       of HIV infection. HIV-IT therapy deposits two genes (env and rev) that
       eventually attach themselves to the outside of healthy cells, and in
       doing so, hopefully boost the immune response that kills infected cells.
       A larger trial is now enrolling and is seeking HIV-positive individuals
       between 18 and 65 years of age. For complete information, call The
       Network at (800) 734-7104.
 DE    Adolescence  Adult  Aged  *Gene Transfer  Genes, env  Genes, rev
       HIV/GENETICS  HIV Infections/*THERAPY  Human  Middle Age  NEWSLETTER
       ARTICLE  CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

